Ambo Agritec (543678)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 19.54% indicates healthy demand and business expansion
• Piotroski F-Score of 7/9 points to sound overall financial health in profitability, leverage, and efficiency
• Latest quarter shows positive net profit of ₹1 Cr on ₹62 Cr sales, confirming the business is operating profitably
• 52-week high of ₹82 suggests market recognition, though this also raises valuation risk

Concerns

• P/E of 47.32 is far above profit growth of 8.53%, making the stock expensive on earnings basis
• Sales growth of 19.54% outpaces profit growth of 8.53%, indicating margin compression
• Latest quarter net margin is only ~1.6%, leaving a thin buffer against raw material price swings
• No dividend and PEG of 3.37 mean investors rely solely on price appreciation for returns

AI Analysis

Looking at Ambo Agritec, I see a classic case of a small commodity business that has caught market enthusiasm. At ₹75.70, market cap ₹99 Cr, the stock trades at 47 times earnings. That is a rich price for a company whose net profit grew only 8.53% while sales grew 19.54%. Revenue is expanding, but profits are not keeping up, implying eroding margins. The latest quarter tells the tale: ₹62 Cr of sales produced just ₹1 Cr of net profit, a thin 1.6% margin. Edible oil is a competitive commodity business with limited pricing power. ROCE of 8.63% barely clears the cost of capital, and with zero dividend yield, shareholders are entirely dependent on price appreciation. The Piotroski F-Score of 7/9 does suggest reasonable financial health, but that does not compensate for a PEG of 3.37 against single-digit profit growth. The stock has surged from ₹15.65 to ₹82 in a year, so much of the optimism may already be in the price. Graham would say price is what you pay, value is what you get. At 47 times earnings, I am asked to pay for perfection. With no book value, ROE, or debt data disclosed, I cannot fully assess the downside. This looks like a cyclical uptrend in sales being mistaken for sustainable quality. I will wait for either a meaningful fall in price or clear evidence that profit growth can catch up with the valuation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer